RICHARD KNAPP: Open Payments
NPI 1134407018 · MADISON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 44 payments from 15 companies in 2025. Trend: 2023 $1,320 · 2024 $1,148 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $255 |
| Zynex Medical, Inc. | 1 | $148 |
| PFIZER INC. | 9 | $137 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| QOL Medical, LLC | 1 | $25 |
Products named: Ozempic, Nexwave, PREVNAR 20, ENTYVIO, Rybelsus, Wegovy, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across WV — which companies pay providers there.
